Milestone Scientific Inc. announced the launch of its Wand® Ambassador Program on January 6 2026, a peer‑to‑peer engagement model designed to accelerate adoption of the Wand STA system in the U.S. dental market.
The program began with a pilot of six ambassadors on December 8 2025, and early feedback has been encouraging. Milestone plans to expand the program to roughly 250 ambassadors over the next 12 months, with the goal of driving a 2‑ to 3‑fold increase in product demonstrations and improving demo‑to‑sales conversion efficiency.
The initiative leverages direct clinical relationships and structured education to strengthen market awareness. By tapping experienced practitioners, Milestone aims to increase the frequency of product demos and the likelihood that those demos convert into sales, addressing a known bottleneck in the dental anesthesia market and translating into higher revenue volume.
Milestone’s Q3 2025 earnings provide context for the program’s potential impact. The company posted an EPS loss of $0.01 versus an expected $0.02, a beat of $0.01, and revenue of $2.36 million against a $2.21 million forecast. The company has been operating at a loss, with a net loss of $6.67 million for the year ended September 30 2025, but it reported a 74.5% gross margin in Q1 2024, indicating a solid cost base that can support the program’s expansion.
The Wand STA system competes with other dental anesthesia delivery systems. Milestone differentiates itself through patient comfort and reduced collateral numbness. The Ambassador Program is intended to give the company a competitive edge by increasing brand visibility and trust among practitioners, thereby accelerating market penetration.
CEO Eric C. Hines said the early response has been encouraging and that the program will build clinical confidence and drive value for shareholders. He emphasized the importance of peer influence in driving adoption and highlighted the program’s role in the company’s broader growth strategy.
Analysts noted the program as a positive development, citing its potential to boost product demonstrations and sales conversion. The announcement followed a recent earnings beat that had already improved investor sentiment.
Milestone plans to monitor ambassador engagement and conversion metrics closely, with the goal of scaling the program to 250 ambassadors within a year. The company remains focused on improving financial performance while expanding its market share in the dental segment.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.